Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

February 6, 2024

https://www.globenewswire.com/news-release/2024/02/06/2824225/0/en/Fulcrum-Therapeutics-to-Participate-at-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html

CAMBRIDGE, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq:FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will present a corporate overview at the Oppenheimer 34th Annual Healthcare Life Sciences Conference, being held virtually on Tuesday, February 13, 2024 at 1:20 p.m. ET. Management will also participate in one-on-one investor meetings.

Read more at globenewswire.com

Related news for (FULC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.